In Gram-negative bacteria where colistin (polymyxin E) exhibits its bactericidal effect, it acts as a membrane disruptor by interacting with Lipopolysaccharide (LPS) and phospholipids in the outer cell membrane. Both cell membranes are damaged due to the competitive displacement of divalent cations Mg 2+ and Ca 2+ from the phosphate groups of membrane lipids [1], leading to intracellular content leakage and eventual bacterial mortality. Most members belonging to the order Enterobacterales, including Salmonella, Klebsiella, Shigella, E. coli and Enterobacter, as well as other medically significant Gram-negative bacteria such as Pseudomonas aeruginosa and Acinetobacter baumannii can be controlled using polymyxins. This class of antibiotics on the other hand, has no known effect against Gram-positive and Gram-negative cocci. Similarly, polymyxins show no activity against Gram-positive bacilli. Furthermore, these drugs are non-efficacious against intrinsically resistant bacteria such as Neisseria, Providencia, Serratia, Stenotrophomonas and Proteus spp., Morganella morganii, Burkholderia, pseudomallei, and Edwardsiella tarda, as well as anaerobic bacteria [2,3].
Burden of ResistanceColistin products are provided to a wide range of animal species in Europe, including poultry, pigs, cattle, sheep, goats, rabbits and laying hens as well as to milk-producing species such as cattle, sheep and goats to treat gastrointestinal illnesses resulting from Gram-negative bacteria such as diarrhea in pigs caused by E. coli and Salmonella spp. as well as colibacillosis prevalent in poultry [4]. This practice increases the possibility of the presence of colistin in wastewater from livestock sources. The high prevalence of colistin-resistant Gramnegative bacteria in livestock feces, process waters and wastewater from slaughterhouses and eventually wastewater treatment plants implies that these sites represent potential reservoirs with the possibility of contributing to the resistance progressing to other natural